Immune Myocarditis Overlapping With Myasthenia Gravis Due to Anti-PD-1 Treatment for a Chordoma Patient: A Case Report and Literature Review

Immune Myocarditis Overlapping With Myasthenia Gravis Due to Anti-PD-1 Treatment for a Chordoma Patient: A Case Report and Literature Review

Immunotherapy begins to be widely used due to the increasing exploration and gratifying effects in multiple cancers. Chordoma, as a rare bone malignant tumor, often recurs and metastasizes after undergoing surgery and radiotherapy. Therefore, immunotherapy can be explored as an emerging, potentially...

Descripción completa

Detalles Bibliográficos
Autores principales: Shujing Liang, Jingxian Yang, Yun Lin, Tong Li, Wenrong Zhao, Jun Zhao, Chunyan Dong
Formato: Artículo
Lenguaje:English
Publicado: Frontiers Media S.A. 2021-07-01
Colección:Frontiers in Immunology
Materias:
chordoma
immune checkpoint inhibitor
PD-1 blockade
sintilimab
myocarditis
myasthenia gravis
Acceso en línea:https://www.frontiersin.org/articles/10.3389/fimmu.2021.682262/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2021.682262/full

Ejemplares similares